Robert Weisskoff
Senior Partner·F-Prime
Cambridge, MA, USA
Robert Weisskoff is a Senior Partner at F-Prime, where he joined in 2004 after senior R&D and business development roles in pharmaceutical and medical device companies. He previously held academic roles at Harvard Medical School, the Harvard-MIT Health Sciences Technology Program, and Massachusetts General Hospital’s MGH-NMR Center. He serves on boards including Adela, Affinia Therapeutics, Countable Labs, Plasmagen Biosciences, RareCyte, Shinobi Therapeutics, and Zenflow.
See the rest of Robert Weisskoff's profile.
Deal history, investment focus, outreach angles and the rest of the background. One email, no password — we send a link and you land right back here.